PharmaShots | Incisive News in 3 Shots

Subscribe Now

Cystic Fibrosis

ReCode Therapeutics Reports the Preclinical Data of RCT2100 for Cystic Fibrosis

ReCode Therapeutics Reports the Preclinical Data of RCT2100 for Cystic Fibrosis

September 27, 2024

SpliSense’s IND of SPL84 Receives the US FDA’s Clearance to Conduct P-II Study for Treating Cystic Fibrosis

SpliSense’s IND of SPL84 Receives the US FDA’s Clearance to Conduct P-II Study for Treating Cystic Fibrosis

April 4, 2024

Vertex Receives CHMP’s Positive Opinion for Kalydeco as a Treatment of Cystic Fibrosis in Infants

Vertex Receives CHMP’s Positive Opinion for Kalydeco as a Treatment of Cystic Fibrosis in Infants

February 23, 2024

Intellia Therapeutics and ReCode Therapeutics Enter into a Collaboration Agreement to Develop Novel Gene Editing Therapies for Cystic Fibrosis (CF)

Intellia Therapeutics and ReCode Therapeutics Enter into a Collaboration Agreement to Develop Novel Gene Editing Therapies for Cys...

February 17, 2024

Vertex’s Kaftrio+Ivacafor Receives EC’s Approval for the Treatment of Children aged 2 to 5yrs. with Cystic Fibrosis (CF)

Vertex’s Kaftrio+Ivacafor Receives EC’s Approval for the Treatment of Children aged 2 to 5yrs. with Cystic Fibrosis (CF)

November 24, 2023

ATUM Extend its Collaboration with Anagram Therapeutics to Develop Enzyme Therapies for Malabsorption and Nutrient Metabolism Disorders

ATUM Extend its Collaboration with Anagram Therapeutics to Develop Enzyme Therapies for Malabsorption and Nutrient Metabolism Diso...

October 5, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us